Informace o projektu
PRECIPITATION OF SCHIZOPHRENIA-LIKE PHENOTYPE BY PRENATAL INFLUENCES: ASSESSING THE ROLE OF THE ENDOCANNABINOID SYSTEM
(ncRNAPain)
- Kód projektu
- 3SGA5789
- Období řešení
- 10/2013 - 9/2016
- Investor / Programový rámec / typ projektu
-
Jihomoravský kraj
- SoMoPro
- Granty pro zahraniční vědce
- Fakulta / Pracoviště MU
- Středoevropský technologický institut
- WWW stránky projektu
- https://www.muni.cz/ceitec/research/projects/25465
- Klíčová slova
- Chronická bolest, neuropatická bolest, Komplexní regionální bolestivý syndrom, KRBS, diabetická neuropatie, bolestivá neuropatie, neuroimunitní komunikace, myší model boelsti, patofyziologie bolesti, dráhy bolesti,, mechanizkus bolesti
Epidemiological studies suggest that heavy cannabis consumption during pregnancy may represent an important risk factor to adverse neurodevelopmental outcomes as schizophrenia (SCZ) in adulthood, which symptoms lead to severe personal and social dysfunctions. There is therefore a need to assess new potential neurobiological mechanisms and furthemore to improve therapeutic interventions. Thus, through an innovative approach we will evaluate carrying out molecular, neurochemical and behavioral studies the degree of endocannabinoid signaling modification in the pathophysiology of SCZ as a neurodevelopmental disorder. The aim will be achieved by comparing the effects of prenatal/perinatal Δ9-THC exposure to those induced by the prenatal treatment with the methylazoxymethanol (MAM) acetate, a well validated neurodevelopmental model in rats. Significant attention will be given to the vulnerability of the offspring to develop neonatal behavior deficits as well as a SCZ-like phenotype at different age (from adolescent to adulthood) and how the treatment with novel cannabinoid-related agents could interfere with this phenotype. The structural changes of several brain regions related to the neurotransmitter system alterations will be correlated to the behavioral responses of the animals and the gender-based difference both to develop SCZ-like symptoms and to the pharmacological treatment will be assessed. Despite the limits of an experimental animal model per se, it is expected that results of this proposal will update our knowledge on the pathophysiological bases of SCZ, as a neurodevelopmental disorder, opening new perspectives to ameliorate the present therapeutic protocols.
Publikace
Počet publikací: 15
2017
-
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia
Neurotoxicity research, rok: 2017, ročník: 32, vydání: 1, DOI
-
Vliv akutní dávky a chronického podání olanzapinu na funkční změny mozku u potkana
Rok: 2017, druh: Další prezentace na konferencích
2015
-
Early modification of the endocannabinoid system accompanies the late behavioral phenotype of rodent neurodevelopmental model of schizophrenia
Rok: 2015, druh: Konferenční abstrakty
-
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system
Rok: 2015, druh: Konferenční abstrakty
-
Specific manner of neuronal subtypes modulation by cannabinoid CB1 receptors in emotional disorders
Rok: 2015, druh: Další prezentace na konferencích